EL-102,99.76%
产品编号:Bellancom-16187| CAS NO:1233948-61-2| 分子式:C19H16N2O3S2| 分子量:384.47
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
EL-102
| 产品介绍 | EL-102 是 hypoxia-induced factor 1 (Hif1α) 的抑制剂。EL-102 诱导细胞凋亡,抑制微管蛋白聚合,并显示抗前列腺癌活性。EL-102 可用于癌症的研究。 | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | EL-102 is a hypoxia-induced factor 1 (Hif1α) inhibitor. EL-102 induces apoptosis, inhibits tubulin polymerisation and shows activities against prostate cancer. EL-102 can be used for the research of cancer. | ||||||||||||||||||||||||||||||||||||||||||||||||
| 体外研究 |
EL-102 (0-120 nM; 72 h) inhibits prostate cancer cells proliferation in vitro. EL-102 (0-100 nM; 72 h) shows cytotoxicity to prostate cancer cell lines. EL-102 (10-100 nM; 24-72 h) induces cellular apoptosis and affects cell cycle. EL-102 (10-100 nM; 24-48 h) affects PARP cleavage in DU145 cells. EL-102 (5 nM; 0-60 min) inhibits tubulin polymerisation activity. EL-102 (0-100 nM; 1 hour) inhibits Hif1α protein expression. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation Assay
Cell Cytotoxicity Assay
Apoptosis Analysis
Western Blot Analysis
Cell Cycle Analysis
Western Blot Analysis
|
||||||||||||||||||||||||||||||||||||||||||||||||
| 体内研究 (In Vivo) |
EL-102 (12 and 15 mg/kg; p.o. 5-day on and 2-day off, from 13 to 37 days after tumour transplantation) potentiates effects of docetaxel in vivo. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||||||||||||||||||||||||||
| 体内研究 |
EL-102 (12 and 15 mg/kg; p.o. 5-day on and 2-day off, from 13 to 37 days after tumour transplantation) potentiates effects of docetaxel in vivo. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||||||||||||||||||||||||||
| 体内研究 |
EL-102 (12 and 15 mg/kg; p.o. 5-day on and 2-day off, from 13 to 37 days after tumour transplantation) potentiates effects of docetaxel in vivo. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||||||||||||||||||||||||||
| 性状 | Solid | ||||||||||||||||||||||||||||||||||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : ≥ 36 mg/mL (93.64 mM) * "≥" means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||||||||||||||||||||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||||||||||||||||||||||||||
| 储存方式 |
| ||||||||||||||||||||||||||||||||||||||||||||||||
| 参考文献 |

浙公网安备 33010802013016号